CANC

CANC
About Tema Oncology ETF
The Tema Oncology ETF (CANC) is designed to strategically invest in companies well-positioned to capitalize on significant advancements within cancer-focused biotechnology and the broader healthcare sector.
About Tema Oncology ETF
The Tema Oncology ETF (CANC) is designed to strategically invest in companies well-positioned to capitalize on significant advancements within cancer-focused biotechnology and the broader healthcare sector.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
RVMD | Revolution Medicines, Inc. | 6.01% | 63.25K | $11.63M |
LLY | Eli Lilly and Company | 5.04% | 8.27K | $9.77M |
COGT | Cogent Biosciences, Inc. | 4.78% | 247.30K | $9.26M |
MRK | Merck & Co., Inc. | 3.47% | 54.23K | $6.73M |
JNJ | Johnson & Johnson | 3.38% | 25.43K | $6.56M |
BMY | Bristol-Myers Squibb Company | 3.38% | 110.38K | $6.55M |
LEGN | Legend Biotech Corporation | 3.27% | 246.19K | $6.34M |
ABBV | AbbVie Inc. | 3.26% | 25.50K | $6.32M |
IMNM | Immunome, Inc. | 3.23% | 274.54K | $6.26M |
EXEL | Exelixis, Inc. | 2.87% | 99.18K | $5.56M |
CGON | CG Oncology Inc. | 2.63% | 70.33K | $5.10M |
IDYA | IDEAYA Biosciences, Inc. | 2.60% | 139.07K | $5.03M |
AMGN | Amgen Inc. | 2.57% | 13.80K | $4.97M |
BBIO | BridgeBio Pharma, Inc. | 2.55% | 59.54K | $4.95M |
GMAB | Genmab A/S | 2.42% | 162.63K | $4.68M |
CELC | Celcuity Inc. | 2.24% | 41.88K | $4.35M |
ONC | BeOne Medicines AG | 1.85% | 11.77K | $3.58M |
RLAY | Relay Therapeutics, Inc. | 1.75% | 180.97K | $3.39M |
ERAS | Erasca, Inc. | 1.73% | 186.77K | $3.34M |
HALO | Halozyme Therapeutics, Inc. | 1.70% | 43.24K | $3.29M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
Holdings (Top 20)
RVMD
Revolution Medicines, Inc.
LLY
Eli Lilly and Company
COGT
Cogent Biosciences, Inc.
MRK
Merck & Co., Inc.
JNJ
Johnson & Johnson
BMY
Bristol-Myers Squibb Company
LEGN
Legend Biotech Corporation
ABBV
AbbVie Inc.
IMNM
Immunome, Inc.
EXEL
Exelixis, Inc.
CGON
CG Oncology Inc.
IDYA
IDEAYA Biosciences, Inc.
AMGN
Amgen Inc.
BBIO
BridgeBio Pharma, Inc.
GMAB
Genmab A/S
CELC
Celcuity Inc.
ONC
BeOne Medicines AG
RLAY
Relay Therapeutics, Inc.
ERAS
Erasca, Inc.
HALO
Halozyme Therapeutics, Inc.
